# Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction

> **NCT05466968** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xiaolu Li** · enrollment: 116 (estimated)

## Conditions studied

- Acute Myocardial Infarction

## Interventions

- **DRUG:** Suxiao Jiuxin Pills
- **DRUG:** The placebo of Suxiao Jiuxin Pills

## Key facts

- **NCT ID:** NCT05466968
- **Lead sponsor:** Xiaolu Li
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2025-06
- **Final completion:** 2027-06
- **Target enrollment:** 116 (ESTIMATED)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05466968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05466968, "Intervention of Suxiao Jiuxin Pill on Instability of Vulnerable Plaque in Acute Myocardial Infarction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05466968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*